Apollo Hospitals Stock Price - ₹8,692.00 | Healthcare Services

‌
‌
‌

Company insights, generated from the most recent coverage.

Integrated ecosystem (hospitals, pharmacy, diagnostics, digital) enables cross-selling and increases patient lifetime value through seamless care continuum.
Read more
Keimed merger gives Apollo 2x scale vs nearest competitor, creating supply chain efficiencies and omnichannel dominance in pharmacy and diagnostics.
Read more
Superior ROCE (21.65%) and ROE (22.64%) vs peers justify valuation premium, reflecting proven execution and integrated ecosystem advantages.
Read more

‌
‌
‌

The Quarter story

The two most recent quarterly results, compared side-by-side.

Apollo Hospitals shows strong profitability and network expansion, though recent revenue and volume dips point to partial quarter reporting.

Hospital EBIT grew from ₹5,610 Cr to ₹6,820 Cr from Q1 FY26 to Q1 FY27, demonstrating consistent profitability

Consolidated revenue fell from ₹29,351 Cr to ₹11,395 Cr from Q1 FY26 to Q1 FY27, suggesting seasonal or reporting variance

EBITDA margin expanded from 9.3% to 24.2% from Q1 FY26 to Q1 FY27, signaling strong cost control

Inpatient volume dropped from 151,558 to 15,370 from Q1 FY26 to Q1 FY27, likely reflecting a partial quarter report

Diagnostics footfalls per day rose from 20,820 to 24,778 from Q1 FY26 to Q1 FY27, indicating strong test demand

Pharmacy store count grew from 6,742 to 7,440 from Q1 FY26 to Q1 FY27, expanding the retail footprint

Hospital occupancy rate climbed from 65% to 70% from Q1 FY26 to Q1 FY27, reflecting improved bed utilization

‌
‌
‌

In the news

Private hospitals add 34,000 beds but meet only 1.4% of demand

Apollo Hospitals, Max Healthcare Eye India's 100K Bed Shortage

Trading Ideas: 15 Stocks for August 17 with Technical Setups

Hospital Sector Shows Strong Q1 Growth Despite Capacity Expansion Challenges

Top 10 stocks rated 'Buy' offer 11-42% upside potential

Nifty hits 5-month high at 23,774; Apollo Hospitals gains 0.54%

Zydus-Apollo Shield MCD Partnership: India's Cancer Screening Revolution

Top 10 stocks rated 'Buy' show 17-48% upside potential

Max Healthcare Gets 'Hold' Rating Despite 4,000 Bed Expansion Plans

Apollo Hospitals' ₹17.76 Crore FEMA Settlement: What It Means

Healthcare stocks surge 27% in FY27, analysts see 17% upside potential

Market correction nearing end; pharma, banking bets advised

Apollo Hospitals Expands Network to 13,100 Beds

Morgan Stanley Raises Timken Target to $140, Maintains Bullish Views

Top stocks to BUY, SELL or HOLD Today: ITC, Page Industries, JSW Cement

Apollo Hospitals Q4 profit surges 36%, stock up 2.85%

Apollo Hospitals hits 52-week high on strong Q4 results

Apollo Hospitals hits 52-week high on strong Q4 earnings

Stocks to Watch Today: Apollo Hospitals, Jubilant Foodworks, Lenskart

Apollo Hospitals Q4 profit jumps 36% to ₹529 cr, FY26 profit up 34%

Apollo Hospitals